ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition

Objective: Osteoarthritis (OA) is a common subtype of arthritis. To date, treatment of OA focuses primarily on alleviating pain and improving joint function. The lack of a vascular system within synovial joints and the rapid removal of agents due to synovial exchange hinder continuous delivery of OA...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Xiaodong Wu, Pengpeng Li, Jian Cheng, Qiang Xu, Beiji Lu, Conghui Han, Weiling Huo
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2021-01-01
Serier:	Frontiers in Bioengineering and Biotechnology
Fag:	osteoarthritis (OA) reactive oxygen species (ROS) nanomicelle dexamethasone cartilage-derivedmor-phogeneticprotein-1 (CDMP-1)
Online adgang:	https://www.frontiersin.org/articles/10.3389/fbioe.2021.608150/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!